0001607062-21-000244.txt : 20210802 0001607062-21-000244.hdr.sgml : 20210802 20210802080409 ACCESSION NUMBER: 0001607062-21-000244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210729 FILED AS OF DATE: 20210802 DATE AS OF CHANGE: 20210802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETKANAS DEAN CENTRAL INDEX KEY: 0000944235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55657 FILM NUMBER: 211134801 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROPATHIX, INC. CENTRAL INDEX KEY: 0001615999 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462645343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 858-883-2642 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 FORMER COMPANY: FORMER CONFORMED NAME: Neuropathix, Inc. DATE OF NAME CHANGE: 20201112 FORMER COMPANY: FORMER CONFORMED NAME: Kannalife Inc DATE OF NAME CHANGE: 20181113 FORMER COMPANY: FORMER CONFORMED NAME: TYG Solutions Corp. DATE OF NAME CHANGE: 20140821 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2021-07-29 0 0001615999 NEUROPATHIX, INC. NPTX 0000944235 PETKANAS DEAN 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 1 1 0 Chief Executive Officer Common Stock 2021-07-29 4 A 0 1875000 0.048 A 24859029 I See Note The reporting person agreed to accept 1,875,000 restricted shares of the issuers common stock in exchange for the discharge of an aggregate of $90,000 of accrued but unpaid monies payable by the issuer to the reporting person as a portion of his salary. The issuance was completed on July 29, 2021. The price of the shares acquired by the reporting person is equal to the closing price of the Company's common stock on July 28, 2021, which was $0.048 per share. Aggregate amount of shares beneficially owned by the reporting person includes shares held by him directly as well as indirectly through Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC. The reporting person disclaims beneficial ownership of the securities held by Powerlife Phytomedical, LLC and Golden Gate Capital Partners, LLC, except to the extent of his pecuniary interest therein. /s/ Dean Petkanas 2021-08-02